ライフサイエンスコーパス: luteal phase

1 its precursors) were associated with shorter luteal phase.

2 ity (P = 0.09) during menses than during the luteal phase.

3 id-follicular phase to the symptomatic, late luteal phase.

4 ncreased from the mid-follicular to the late luteal phase.

5 ic environment during the follicular vs. the luteal phase.

6 cination in the follicular phase but not the luteal phase.

7 the development of mood symptoms during the luteal phase.

8 vels as follicular cells transition into the luteal phase.

9 domised order: late follicular phase and mid-luteal phase.

10 r for half of the menstrual cycle during the luteal phase.

11 teins (P = 5.62E-4) were elevated during the luteal phase.

12 e of 18 proteins that best distinguished the luteal phase.

13 n </= 5 ng/mL and no LH peak in the mid/late luteal phase.

14 wer endometrial expression of FST during the luteal phase.

15 rgery during the follicular phase versus the luteal phase.

16 eft fronto-polar cortex more than during the luteal phase.

17 ating hormone and luteinizing hormone in the luteal phase.

18 d a 0.06-log(PdG) decrease (p = 0.03) in the luteal phase.

19 ficantly associated with length of the prior luteal phase.

20 icular phase and then decreased again in the luteal phase.

21 ls the entire night in the luteal and pseudo luteal phase.

22 se, and 0.76 +/- 0.07 kJ/min during the late luteal phase.

23 -cycle compared with both the follicular and luteal phases.

24 een the early follicular, ovulatory, and mid-luteal phases.

25 ed twice, during the late-follicular and mid-luteal phases.

26 in females (n = 12) in their follicular and luteal phases.

27 E1 were determined during the follicular and luteal phases.

28 follicular phase to the mid luteal and late luteal phases.

29 levels during the follicular, ovulatory, and luteal phases.

30 easured in the early and late follicular and luteal phases.

31 sion showed that decreases in follicular and luteal phase 17beta-estradiol levels were positively ass

32 hthalate (MCOP) were associated with shorter luteal phase [2nd tertile vs. 1st tertile: -0.5 days (95

33 BPA was also associated with shorter luteal phase [2nd vs. 1st: -0.8 days (95% CI: -1.2, -0.4

34 men comprised the study cohort: 230 (28%) in luteal phase; 363 (44%) in follicular phase; and 241 gro

35 ase (59 [17]) compared with women during the luteal phase (53 [14]) and compared with men (46 [16]; P

36 tal cortex and amygdala more than during the luteal phase (6-10 days after luteinizing hormone surge)

37 103), and BPS participants (n = 23) in their luteal phase across a bladder-filling task.

38 t driven by the follicular compared with the luteal phase and directly related to craving and fluctua

39 ic the decidualizing steroidal milieu of the luteal phase and early pregnancy.

40 transformation of the endometrium during the luteal phase and evaluate markers of endometrial recepti

41 ition of uILCs in the endometrium during the luteal phase and in the decidua during early pregnancy.

42 onth, once during their active pill phase or luteal phase and once during their pill pause or menses.

43 traception could mimic the high-progesterone luteal phase and predispose women to human immunodeficie

44 cular phase, 0.70 +/- 0.10 kJ/min during the luteal phase, and 0.76 +/- 0.07 kJ/min during the late l

45 e onset of melatonin levels for women in the luteal phase, but it had little effect on melatonin leve

46 not meet criteria for either follicular- or luteal-phase categories.

47 ins indicates that AR(-/-) females exhibit a luteal phase defect.

48 poradic anovulation, irregular cycle length, luteal phase deficiency, long menses, and heavy blood lo

49 e the estradiol during the follicular versus luteal phase (Delta), the higher the Deltadrug cue react

50 mones measured either midcycle or during the luteal phase, despite good statistical power to detect m

51 tinuous (full-cycle dosing) or intermittent (luteal-phase dosing) sertraline.

52 e anxiety and dysphoria associated with late luteal phase dysphoria disorder and major unipolar depre

53 trajectory showed that its left shift in the luteal phase (e.g., earlier rise in progesterone) expose

54 lection of gene expression profiles from mid-luteal phase endometrial biopsies (n = 115) from women e

55 o [OR] 1.11, 95% CI 1.03-1.20; p=0.0063) and luteal phase endometrial thickness lower (0.90, 0.83-0.9

56 IUD transcriptome was indistinguishable from luteal phase endometrium.

57 g was associated with decreased midcycle and luteal-phase estradiol levels.

58 5-1988) of a prospective study, midcycle and luteal-phase estrogens and progestins were measured in 1

59 Luteal-phase females showed diminished subjective drug e

60 During the late luteal phase, females showed a lower predicted binge dri

61 lar phase was more irregular than during the luteal phase for both FSH and LH (P < 0.01).

62 of the menstrual cycle (n=30) or the pseudo luteal phase for oral contraceptive users (n=32).

63 in the vaginal lumen and increase during the luteal phase (high progesterone).

64 articular susceptibility observed during the luteal phase in nonhuman primate models and ex vivo huma

65 ereas drug reappraisal was higher during the luteal phase in the anterior PFC/orbitofrontal cortex.

66 arker to distinguish the follicular from the luteal phase in univariate and multivariate analyses and

67 th, 16.0 (standard deviation, 4.4) days; and luteal phase length, 12.9 (standard deviation, 1.7) days

68 w or a window determined by assuming a fixed luteal phase length, would be simpler.

69 and increased follicular phase and decreased luteal phase lengths; Hispanic ethnicity with anovulatio

70 sing linear mixed models for follicular- and luteal-phase lengths, discrete-time fecundability models

71 ese chemicals in relation to follicular- and luteal-phase lengths, time to pregnancy, and early pregn

72 ated from sputum during exacerbations in the luteal phase (low estradiol).

73 any of the following cycle endpoints: short luteal phase (< or = 10 days), long follicular phase (>

74 to an increased risk for anovulation, short luteal phase (< or =10 days), long follicular phase (> o

75 ion of Oocyte Retrieval performed during the Luteal Phase (LuPOR) in poor responders, as defined by t

76 Multiple network aberrations during the luteal phase may explain the development of mood symptom

77 en during the early follicular (EFP) and mid-luteal phase (MLP) of the menstrual cycle.

78 Luteal phase MPS was 1.28 +/- 0.27% d(-1) in the control

79 Sodium cravings increased in the luteal phase of all cycles but were not accompanied by i

80 l magnetic resonance imaging during the late luteal phase of fifty-one women diagnosed with PMDD, com

81 er FC during the midfollicular than the late-luteal phase of PMDD.

82 ons comparable to levels observed during the luteal phase of premenopausal women and were significant

83 myomata than myometrium, but only during the luteal phase of the cycle.

84 a1-induced COL1 protein abundance in the mid-luteal phase of the estrous cycle after 48 h (p < 0.05).

85 ats mimics the progesterone component of the luteal phase of the human menstrual cycle, these finding

86 ature levels in women were tested during the luteal phase of the menstrual cycle (n=30) or the pseudo

87 omen using no long-term contraceptive in the luteal phase of the menstrual cycle also had a 3.25 time

88 discrimination of facial emotions during the luteal phase of the menstrual cycle and altered reactivi

89 h levels comparable to those observed in the luteal phase of the menstrual cycle and modestly increas

90 The results for women in the luteal phase of the menstrual cycle are consistent with

91 egnanolone levels from the follicular to the luteal phase of the menstrual cycle by blocking the conv

92 s were significantly (P=0.0078) lower in the luteal phase of the menstrual cycle compared to the foll

93 Changes in neurosteroid levels during the luteal phase of the menstrual cycle may precipitate affe

94 onadotropin secretion was blocked during the luteal phase of the menstrual cycle with a gonadotropin-

95 istered to female rhesus macaques during the luteal phase of the menstrual cycle, 40 min before admin

96 T cell populations were detected during the luteal phase of the menstrual cycle, and longitudinal an

97 In conclusion, TEF decreased during the luteal phase of the menstrual cycle, possibly as a resul

98 often occur during pregnancy and during the luteal phase of the menstrual cycle, when levels of prog

99 behavioral, and somatic symptoms in the late luteal phase of the menstrual cycle.

100 rder and 11 healthy female volunteers in the luteal phase of the menstrual cycle.

101 with plasma estradiol and estrone during the luteal phase of the menstrual cycle.

102 did not result from sodium retention in the luteal phase of the menstrual cycle.

103 al Dysphoric Disorder (PMDD) during the late luteal phase of the menstrual cycle.

104 esistance exercise in the follicular vs. the luteal phase of the menstrual cycle.

105 terized by debilitating mood symptoms in the luteal phase of the menstrual cycle.

106 V infection during the progesterone-dominant luteal phase of the menstrual cycle.

107 vulation phase and with urine PdG during the luteal phase of the menstrual cycle.

108 During the luteal phase of the sodium restriction cycle, significan

109 rovided) were measured in the follicular and luteal phases of 2 menstrual cycles before a single inje

110 of the first menstrual cycle and during the luteal phases of both the first and third menstrual cycl

111 valuated in clinic during the follicular and luteal phases of each menstrual cycle.

112 metrial explants from the follicular and mid-luteal phases of the estrous cycle.

113 l females, and females in the follicular and luteal phases of the menstrual cycle (FDR-adjusted p-val

114 in the younger women (in the follicular and luteal phases of the menstrual cycle).

115 days apart to distinguish the follicular and luteal phases of the menstrual cycle, and phases were co

116 e glucuronide (E1G) in the periovulatory and luteal phases of the menstrual cycle, and to assess the

117 women during the the mid-follicular and late luteal phases of the menstrual cycle.

118 wice, at the (1) late follicular and (2) mid luteal phases of the menstrual cycle.

119 ding with the follicular, periovulatory, and luteal phases of their menstrual cycle were studied.

120 ching task during the midfollicular and late-luteal phases of their menstrual cycle.

121 lab during the follicular, ovulatory and mid-luteal phases of their menstrual cycles.

122 fertility (n = 5) during the follicular and luteal phases of their reproductive cycles.

123 Shedding increased during the luteal phase only among women with CD4 counts of <350 ce

124 bitors, taken throughout the cycle or during luteal phases only, is also well established.

125 s increased sixfold to eightfold in the late luteal phase (P < 0.001) and those of swelling or bloati

126 and neutrophil gene set signatures with the luteal phase (P < 0.05).

127 re higher in the late follicular than in the luteal phase (P = 0.02 and P = 0.04, respectively).

128 re higher in the late follicular than in the luteal phase (P = 0.03 and P = 0.02, respectively).

129 nsive pregnancies were tested during the mid-luteal phase (PRE) and early pregnancy (EARLY; 6.2 +/- 1

130 romedial prefrontal cortex and, in the early luteal phase, reduced central and corticomedial amygdala

131 previously, we showed more inhibition in the luteal phase relative to the midfollicular menstrual pha

132 rinking probability and odds ratios vs. late luteal phase, respectively: 17%, odds ratio=1.340, 95% C

133 es during the follicular, periovulatory, and luteal phases, respectively (P = .01).

134 nd increases in progesterone associated with luteal phases, resulting in safe and potentially lifetim

135 ases, and directly with the probability of a luteal-phase rise in progesterone.

136 pooled to create follicular-, midcycle-, and luteal-phase samples, respectively, for analysis.

137 inary sodium loss, not retention, during the luteal phase; severity of menstrual symptoms was unchang

138 Compared to luteal phase sheep, both ERalpha and ERbeta levels in UA

139 d during the follicular phase and during the luteal phase similarly.

140 ed in women with PMDD from follicular to the luteal phases, suggesting the absence of effect of the l

141 Herein, we review the evidence on luteal phase support and highlight remaining uncertainti

142 Despite the proven superiority of various luteal phase support protocols (LPS) over placebo in vie

143 sterone formulations to inform the design of luteal phase support regimens.

144 s used to optimize pregnancy rates; however, luteal phase support remains largely 'black-box' with in

145 gers used to mature oocytes on the degree of luteal phase support required.

146 Consequently, hormonal supplementation with luteal phase support, principally exogenous progesterone

147 ore energy at rest (4.3%; P = 0.0002) in the luteal phase than in the follicular phase.

148 t is greater during the early follicular and luteal phases than in the late follicular (periovulatory

149 ocytes during IVF results in a dysfunctional luteal phase that can be insufficient to support implant

150 Conversely, during the luteal phase there were factors overexpressed (including

151 Median luteal phase titres of progesterone were 121% higher (p=

152 re collected, characterized as follicular or luteal phase using days since last menstrual period, and

153 evel, in the default mode network during the luteal phase when passively viewing negative emotional s

154 ng postovulation (average of luteal and late luteal phases), when it was 0.73 +/- 0.07 kJ/min, compar

155 antly higher than those measured in the late luteal phase, whereas aging and cigarette smoking reduce

156 mmunocytochemically detectable GAL-R1 in the luteal phase, whereas only a twentieth expressed GAL-R1

157 offer candidate mechanisms through which the luteal phase, wherein progesterone is dominant relative

158 Specifically, we outline the physiological luteal phase, which is regulated by progesterone from th

159 modeling and leukocyte infiltration with the luteal phase, which may represent potential hormone-asso